Selbyville, DE -- (SBWIRE) -- 05/09/2019 -- UK pet cancer therapeutics market is estimated to reach USD 14.3 million by 2025. Pet cancer vaccines were available in most of the European regions before chemotherapy drugs. Vaccines market is likely to witness strong growth owing to introduction of new vaccines over the forecast period.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/568794/?utm_source=Releasewire.com-AN

Pet Cancer Therapeutics Market will exceed USD 359.4 million by 2025; as per a new research report. Increasing number of pet owners and pet population will spur industry growth across the forecast timeframe. This is largely because of increasing need for companionship commonly seen in developed countries. Every year, nearly 2% of increase in pet ownership is seen, resulting to growing demand for pet cancer therapeutics.

Chemotherapy dominated the overall market and will reach USD 211.0 million by 2025. High growth is due to considerable number of products available for the control of tumor growth and is preferred in the form of intravenous administration and some are available in the form of oral administrations.

Growing willingness to spend on pet healthcare will boost pet cancer therapeutics market growth. As per American Society for the Prevention of Cruelty to Animals (ASPCA), American pet owner spend an average of USD 235 per year on dogs? health and USD 160 on cats health. As pet owners spend more on pet care, the demand for pet cancer therapeutics will grow in the future.

Dogs dominate the overall pet cancer therapeutics market due to increasing demand for adoption of dogs, willingness of pet owners to provide quality pet care and veterinary treatment, specialty foods and supplements. Furthermore, prevalence of cancer is more in dogs as compared to cats.

Lymphoma dominated the overall pet cancer drugs market and is expected to grow at 19.1% CAGR across the forecast timeframe. Considerable number of products available for the treatment of this cancer that attack pets such as dogs and cats. Lymphoma is the most common type of cancer found in dogs and cats, thereby leading to market growth.

China pet cancer therapeutics market will expand at 12.6% CAGR across the forecast timeframe. Increasing population of dogs, increasing incidence of cancer in dogs, and increasing disposable income of dog owners is stimulating the further growth of pet cancer therapeutics market in China. As a result, the pet cancer treating drugs have been in great demand lately.

Few of the prominent market players involved in global pet cancer therapeutics market are Zoetis, Merial, Aratana Therapeutics, AB Science, Vetivax, VetDC, Regeneus and Karyopharms Verdinexor. The industry participants are engaged in acquisition and collaborations to enhance their market foothold and expand geographic reach.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/568794/?utm_source=Releasewire.com-AN

Table of Content:

Chapter 1. Methodology

1.1. Methodology

1.2. Market definition

1.3. Forecast parameters

1.4. Data sources

1.4.1. Secondary

1.4.1.1. Paid sources

1.4.1.2. Unpaid sources

1.4.2. Primary

Chapter 2. Executive Summary

2.1. Pet cancer therapeutics industry 360 degree synopsis, 2014 - 2025

2.1.1. Business trends

2.1.2. Medicine type trends

2.1.3. Species trends

2.1.4. Cancer type trends

2.1.5. Regional trends

Chapter 3. Pet Cancer Therapeutics Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2014 - 2025

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1. Increasing pet population in the U.S. and Europe

3.3.1.2. Rising prevalence of pet cancer in developed countries

3.3.1.3. Rising awareness of pet owners regarding pet diseases and growing willingness to spend on pet healthcare

3.3.1.4. Growing trend towards new product development

3.3.2. Industry pitfalls & challenges

3.3.2.1. Undesirable effects of pet cancer therapeutics

3.3.2.2. Dearth of veterinary oncologist

3.3.2.3. Low out of pocket expenditure on pet healthcare in developing countries

3.4. Growth potential analysis

3.4.1. By medicine type

3.4.2. By species

3.4.3. By cancer type

3.5. Regulatory landscape

3.5.1. U.S.

3.5.2. Europe

3.6. Technology landscape

3.6.1. U.S.

3.6.2. Europe

3.7. Pipeline analysis

3.8. Porter's analysis

3.9. Competitive landscape, 2017

3.9.1. Strategy dashboard

3.10. PESTEL analysis

Chapter 4. Pet Cancer Therapeutics Market, By Medicine Type

4.1. Key segment trends

4.2. Chemotherapy drugs

4.2.1. Market size, by region, 2014 - 2025 (USD Million)

4.3. Vaccines

4.3.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 5. Pet Cancer Therapeutics Market, By Species

5.1. Key segment trends

5.2. Dogs

5.2.1. Market size, by region, 2014 - 2025 (USD Million)

5.3. Cats

5.3.1. Market size, by region, 2014 - 2025 (USD Million)

About Market Study Report
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com